Astria Therapeutics Overview

Astria Therapeutics Other Income Expense Net

Other Income/Expense Net for ATXS.

Quarterly Other Income/Expense

$2.46M

↓ 45.07% YoY

As of Sep 30, 2025

Annual Other Income/Expense (TTM)

$12.48M

↑ 1252.11% YoY

Trailing 12 months ending Sep 30, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin